Gearing D P, VandenBos T, Beckmann M P, Thut C J, Comeau M R, Mosley B, Ziegler S F
Immunex Research and Development Corporation, Seattle, WA 98101.
Ciba Found Symp. 1992;167:245-55; discussion 255-9. doi: 10.1002/9780470514269.ch15.
cDNA clones encoding the human leukaemia inhibitory factor (hLIF) receptor were isolated by screening a placental cDNA expression library in COS-7 cells with 125I-hLIF. The cloned LIF receptor is a member of the haemopoietin receptor family and comprises a signal sequence (44 amino acids), an extracellular region of two haemopoietin receptor domains and three fibronectin type III domains (789 amino acids), a transmembrane domain (26 amino acids) and a cytoplasmic domain (238 amino acids). The LIF receptor is expressed in COS-7 cells as a 190 kDa glycoprotein that specifically binds human LIF with low affinity, but does not bind mouse LIF. Clones encoding a soluble form of the homologous mouse LIF receptor have been isolated, suggesting complex interactions between the various forms of LIF ligand and receptor in vivo. The LIF receptor is most related to the gp130 signal-transducing component of the IL-6 receptor, a feature that may provide a molecular basis for the intertwined biologies of LIF and IL-6 in the absence of obvious structural similarly between the ligands. Mouse B9 plasmacytoma cells transfected with the human LIF receptor display novel high affinity LIF receptors that are presumed to consist of transfected receptors in association with endogenous mouse high affinity-converting subunits. Unlike the low affinity human LIF receptor, the mixed species high affinity receptor is capable of binding mouse LIF.
通过用¹²⁵I-人白血病抑制因子(hLIF)筛选COS-7细胞中的胎盘cDNA表达文库,分离出编码人白血病抑制因子(hLIF)受体的cDNA克隆。克隆的LIF受体是血细胞生成素受体家族的成员,由一个信号序列(44个氨基酸)、两个血细胞生成素受体结构域和三个纤连蛋白III型结构域的细胞外区域(789个氨基酸)、一个跨膜结构域(26个氨基酸)和一个细胞质结构域(238个氨基酸)组成。LIF受体在COS-7细胞中作为一种190 kDa的糖蛋白表达,它以低亲和力特异性结合人LIF,但不结合小鼠LIF。已经分离出编码同源小鼠LIF受体可溶性形式的克隆,这表明体内各种形式的LIF配体和受体之间存在复杂的相互作用。LIF受体与IL-6受体的gp130信号转导成分最相关,这一特征可能为LIF和IL-6在配体之间缺乏明显结构相似性的情况下相互交织的生物学特性提供分子基础。用人类LIF受体转染的小鼠B9浆细胞瘤细胞显示出新型的高亲和力LIF受体,推测其由转染的受体与内源性小鼠高亲和力转换亚基结合组成。与低亲和力的人LIF受体不同,混合物种高亲和力受体能够结合小鼠LIF。